» Articles » PMID: 25232830

Coverage and Timing of Children's Vaccination: an Evaluation of the Expanded Programme on Immunisation in The Gambia

Overview
Journal PLoS One
Date 2014 Sep 19
PMID 25232830
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the coverage and timeliness of the Expanded Programme on Immunisation (EPI) in The Gambia.

Methods: Vaccination data were obtained between January 2005 and December 2012 from the Farafenni Health and Demographic Surveillance System (FHDSS), the Basse Health and Demographic Surveillance System (BHDSS), the Kiang West Demographic surveillance system (KWDSS), a cluster survey in the more urban Western Health Region (WR) and a cross sectional study in four clinics in the semi-urban Greater Banjul area of WR. Kaplan-Meier survival function was used to estimate the proportion vaccinated by age and to assess timeliness to vaccination.

Findings: BCG vaccine uptake was over 95% in all regions. Coverage of DPT1 ranged from 93.2% in BHDSS to 99.8% in the WR. Coverage decreased with increasing number of DPT doses; DPT3 coverage ranged from 81.7% in BHDSS to 99.0% in WR. Measles vaccination coverage ranged from 83.3% in BHDSS to 97.0% in WR. DPT4 booster coverage was low and ranged from 43.9% in the WR to 82.8% in KWDSS. Across all regions, delaying on previous vaccinations increased the likelihood of being delayed for the subsequent vaccination.

Conclusions: The Gambia health system achieves high vaccine coverage in the first year of life. However, there continues to be a delay to vaccination which may impact on the introduction of new vaccines. Examples of effectively functioning EPI programmes such as The Gambia one may well be important models for other low income countries struggling to achieve high routine vaccination coverage.

Citing Articles

Timely Vaccination and Its Associated Factors Among Parents With Children Aged From 0 to 23 Months in Wolaita Zone Public Hospitals, Southern Ethiopia, 2024: A Facility-Based Cross-Sectional Study.

Geta Hardido T, Atinafu Ataro B, Elifios E Glob Pediatr Health. 2024; 11:2333794X241297034.

PMID: 39610854 PMC: 11603463. DOI: 10.1177/2333794X241297034.


Starting then stopping: a nationwide register-based study on the magnitude, predictors, and urban-rural patterns of under-vaccination variation across health centers in The Gambia.

Sowe A, Namatovu F, Cham B, Gustafsson P Glob Health Action. 2024; 17(1):2348788.

PMID: 38826143 PMC: 11149585. DOI: 10.1080/16549716.2024.2348788.


Timeliness of Vaccination among Children Attending Immunization Clinic at a Tertiary Hospital in South-East Nigeria.

Umeokonkwo A, Ezeonu T, Agu A, Umeokonkwo C Niger Med J. 2024; 62(4):153-161.

PMID: 38694215 PMC: 11058447. DOI: 10.60787/NMJ-62-4-29.


The Enterics for Global Health (EFGH) Surveillance Study in The Gambia.

Conteh B, Badji H, Jallow A, Karim M, Manneh A, Keita B Open Forum Infect Dis. 2024; 11(Suppl 1):S84-S90.

PMID: 38532959 PMC: 10962724. DOI: 10.1093/ofid/ofae049.


Predictors of timeliness of vaccination among children of age 12-23 months in Boricha district, Sidama region Ethiopia, in 2019.

Negash B, Tediso Y, Yoseph A BMC Pediatr. 2023; 23(1):409.

PMID: 37598170 PMC: 10439539. DOI: 10.1186/s12887-023-04234-4.


References
1.
Ndiritu M, Cowgill K, Ismail A, Chiphatsi S, Kamau T, Fegan G . Immunization coverage and risk factors for failure to immunize within the Expanded Programme on Immunization in Kenya after introduction of new Haemophilus influenzae type b and hepatitis b virus antigens. BMC Public Health. 2006; 6:132. PMC: 1475578. DOI: 10.1186/1471-2458-6-132. View

2.
Fadnes L, Jackson D, Engebretsen I, Zembe W, Sanders D, Sommerfelt H . Vaccination coverage and timeliness in three South African areas: a prospective study. BMC Public Health. 2011; 11:404. PMC: 3126743. DOI: 10.1186/1471-2458-11-404. View

3.
Mendy M, Peterson I, Hossin S, Peto T, Jobarteh M, Jeng-Barry A . Observational study of vaccine efficacy 24 years after the start of hepatitis B vaccination in two Gambian villages: no need for a booster dose. PLoS One. 2013; 8(3):e58029. PMC: 3606345. DOI: 10.1371/journal.pone.0058029. View

4.
Kotloff K, Blackwelder W, Nasrin D, Nataro J, Farag T, van Eijk A . The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis. 2012; 55 Suppl 4:S232-45. PMC: 3502307. DOI: 10.1093/cid/cis753. View

5.
Clark A, Sanderson C . Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data. Lancet. 2009; 373(9674):1543-9. DOI: 10.1016/S0140-6736(09)60317-2. View